Most Clicked StoriesMore >


Novartis to divide into 2 business units

BIO SmartBrief | May 18, 2016

Novartis announced it will split its pharmaceuticals unit into separate drug and oncology businesses. Novartis' restructuring plan reflects its focus on oncology after consolidating GlaxoSmithKline's oncology products into its pipeline in 2015, the company said. Reuters (05/17)


Pfizer reaches deal to purchase Anacor for $5.2B

BIO SmartBrief | May 17, 2016

Roche's bladder cancer immunotherapy wins FDA approval

BIO SmartBrief | May 19, 2016

Canada approves AquaBounty's biotech salmon for sale as food

BIO SmartBrief | May 20, 2016

Celgene to develop metabolic immuno-oncology treatments with Agios

BIO SmartBrief | May 18, 2016

Janssen acquires rights to MacroGenics' preclinical cancer molecule

BIO SmartBrief | May 19, 2016

Biogen partners with university for gene therapy development

BIO SmartBrief | May 17, 2016

AbbVie, BMS expand Mass. facilities

BIO SmartBrief | May 18, 2016

Bayer signs CRISPR-Cas9 licensing deal with ERS Genomics

BIO SmartBrief | May 19, 2016

FDA approves trial of Newron's Rett syndrome treatment

BIO SmartBrief | May 19, 2016


Find BIO SmartBrief Issues by Date:



BIO News More >


A better way to purchase office supplies and professional printing

BIO SmartBrief | May 23, 2016

Register for BIO's Executive Training Courses

BIO SmartBrief | May 23, 2016

BIO survey to support PDUFA 6 negotiations

BIO SmartBrief | May 20, 2016

Take advantage of your cost-savings opportunities

BIO SmartBrief | May 19, 2016

Save with UniFirst

BIO SmartBrief | May 18, 2016




Sign up for BIO SmartBrief



Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more